Galectin-3 plays a role in minute virus of mice infection

Virology

Volumn 481, Issue , 2015, Pages 63-72

  Garcin, Pierre O ^a   Nabi, Ivan R ^a   Panté, Nelly ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Galectin 3; Mgat5; Minute virus of mice; MVM; Parvovirus

Indexed keywords

BETA1,6 ACETYLGLUCOSAMINYLTRANSFERASE 5; GALECTIN 3; GLYCAN; N ACETYLGLUCOSAMINYLTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS MIDDLE T ANTIGEN; ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE;

ARTICLE; BINDING AFFINITY; BREAST TUMOR; CANCER CELL CULTURE; CELL ADHESION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; LIGAND BINDING; MINUTE VIRUS OF MICE; MINUTE VIRUS OF MICE INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTION; VIRUS ONCOTROPISM; VIRUS VIRULENCE; ANIMAL; CELL LINE; GENETICS; METABOLISM; MOUSE; PARVOVIRUS INFECTION; PHYSIOLOGY; RODENT DISEASE; VETERINARY; VIROLOGY;

MINUTE VIRUS OF MICE; PARVOVIRUS; POLYOMAVIRUS;

ANIMALS; CELL LINE; GALECTIN 3; HUMANS; MICE; MINUTE VIRUS OF MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PARVOVIRIDAE INFECTIONS; RODENT DISEASES;

EID: 84924618115     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.02.019     Document Type: Article

References (70)

1. Allaume X., El-Andaloussi N., Leuchs B., Bonifati S., Kulkarni A., Marttila T., Kaufmann J.K., Nettelbeck D.M., Kleinschmidt J., Rommelaere J., Marchini A. Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. J. Virol. 2012, 86:3452-3465.
2. Ball-Goodrich L.J., Tattersall P. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J. Virol. 1992, 66:3415-3423.
3. Bantel-Schaal U., Braspenning-Wesch I., Kartenbeck J. Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts. J. Gen. Virol. 2009, 90:317-322.
4. Bayer N., Schober D., Prchla E., Murphy R.F., Blaas D., Fuchs R. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J. Virol. 1998, 72:9645-9655.
5. Boisvert M., Fernandes S., Tijssen P. Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J. Virol. 2010, 84:7782-7792.
6. Boscher C., Dennis J.W., Nabi I.R. Glycosylation, galectins and cellular signaling. Curr. Opin. Cell Biol. 2011, 23:383-392.
7. Boscher C., Nabi I.R. Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells. Mol. Biol. Cell 2013, 24:2134-2145.
8. Boscher C., Zheng Y.Z., Lakshminarayan R., Johannes L., Dennis J.W., Foster L.J., Nabi I.R. Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells. J. Biol. Chem. 2012, 287:32940-32952.
9. Brewer C.F., Miceli M.C., Baum L.G. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 2002, 12:616-623.
10. Burnett E., Tattersall P. Reverse genetic system for the analysis of parvovirus telomeres reveals interactions between transcription factor binding sites in the hairpin stem. J. Virol. 2003, 77:8650-8660.
11. Chiu C.G., Strugnell S.S., Griffith O.L., Jones S.J., Gown A.M., Walker B., Nabi I.R., Wiseman S.M. Diagnostic utility of galectin-3 in thyroid cancer. Am. J. Pathol. 2010, 176:2067-2081.
12. Cooling L.L., Koerner T.A., Naides S.J. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J. Infect. Dis. 1995, 172:1198-1205.
13. Cotmore S.F., Agbandje-McKenna M., Chiorini J.A., Mukha D.V., Pintel D.J., Qiu J., Soderlund-Venermo M., Tattersall P., Tijssen P., Gatherer D., Davison A.J. The family Parvoviridae. Arch. Virol. 2014, 159:1239-1247.
14. Cotmore S.F., Tattersall P. A rolling-hairpin strategy: basic mechanisms of DNA replication in the parvoviruses. Parvoviruses 2006, Hodder Arnold, London. J.R. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
15. Deleu L., Pujol A., Faisst S., Rommelaere J. Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection. J. Virol. 1999, 73:3877-3885.
16. Denard J., Beley C., Kotin R., Lai-Kuen R., Blot S., Leh H., Asokan A., Samulski R.J., Moullier P., Voit T., Garcia L., Svinartchouk F. Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6. J. Virol. 2012, 86:6620-6631.
17. Dennis J.W., Lau K.S., Demetriou M., Nabi I.R. Adaptive regulation at the cell surface by N-glycosylation. Traffic 2009, 10:1569-1578.
18. Dennis J.W., Nabi I.R., Demetriou M. Metabolism, cell surface organization, and disease. Cell 2009, 139:1229-1241.
19. Doerig C., Hirt B., Antonietti J.P., Beard P. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol. 1990, 64:387-396.
20. Doerig C., Hirt B., Beard P., Antonietti J.P. Minute virus of mice non-structural protein NS-1 is necessary and sufficient for trans-activation of the viral P39 promoter. J. Gen. Virol. 1988, 69(Pt 10):2563-2573.
21. Farr G.A., Zhang L.G., Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:17148-17153.
22. Furtak V., Hatcher F., Ochieng J. Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells. Biochem. Biophys. Res. Commun. 2001, 289:845-850.
23. Garcin P., Cohen S., Terpstra S., Kelly I., Foster L.J., Pante N. Proteomic analysis identifies a novel function for galectin-3 in the cell entry of parvovirus. J. Proteomics 2013, 79:123-132.
24. Garcin P.O., Pante N. Cell migration is another player of the minute virus of mice infection. Virology 2014, 468-470C:150-159.
25. Garner O.B., Aguilar H.C., Fulcher J.A., Levroney E.L., Harrison R., Wright L., Robinson L.R., Aspericueta V., Panico M., Haslam S.M., Morris H.R., Dell A., Lee B., Baum L.G. Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation. PLoS Pathog. 2010, 6:e1000993.
26. Geletneky K., Huesing J., Rommelaere J., Schlehofer J.R., Leuchs B., Dahm M., Krebs O., von Knebel Doeberitz M., Huber B., Hajda J. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. BMC Cancer 2012, 12:99.
27. Goetz J.G. Bidirectional control of the inner dynamics of focal adhesions promotes cell migration. Cell Adhes. Migr. 2009, 3:185-190.
28. Goetz J.G., Joshi B., Lajoie P., Strugnell S.S., Scudamore T., Kojic L.D., Nabi I.R. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J. Cell Biol. 2008, 180:1261-1275.
29. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 2000, 6:306-312.
30. Grekova S., Zawatzky R., Horlein R., Cziepluch C., Mincberg M., Davis C., Rommelaere J., Daeffler L. Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism. J. Virol. 2010, 84:516-531.
31. Halder S., Cotmore S., Heimburg-Molinaro J., Smith D.F., Cummings R.D., Chen X., Trollope A.J., North S.J., Haslam S.M., Dell A., Tattersall P., McKenna R., Agbandje-McKenna M. Profiling of glycan receptors for minute virus of mice in permissive cell lines towards understanding the mechanism of cell recognition. PLoS One 2014, 9:e86909.
32. Henderson N.C., Mackinnon A.C., Farnworth S.L., Poirier F., Russo F.P., Iredale J.P., Haslett C., Simpson K.J., Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:5060-5065.
33. Huang L.Y., Halder S., Agbandje-McKenna M. Parvovirus glycan interactions. Curr. Opin. Virol. 2014, 7:108-118.
34. Kaufmann B., Lopez-Bueno A., Mateu M.G., Chipman P.R., Nelson C.D., Parrish C.R., Almendral J.M., Rossmann M.G. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody. J. Virol. 2007, 81:9851-9858.
35. Kern A., Schmidt K., Leder C., Muller O.J., Wobus C.E., Bettinger K., Von der Lieth C.W., King J.A., Kleinschmidt J.A. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 2003, 77:11072-11081.
36. Lajoie P., Goetz J.G., Dennis J.W., Nabi I.R. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 2009, 185:381-385.
37. Lakshminarayan R., Wunder C., Becken U., Howes M.T., Benzing C., Arumugam S., Sales S., Ariotti N., Chambon V., Lamaze C., Loew D., Shevchenko A., Gaus K., Parton R.G., Johannes L. Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nat. Cell Biol. 2014, 16:595-606.
38. Legrand C., Rommelaere J., Caillet-Fauquet P. MVM(p) NS-2 protein expression is required with NS-1 for maximal cytotoxicity in human transformed cells. Virology 1993, 195:149-155.
39. Linser P., Bruning H., Armentrout R.W. Specific binding sites for a parvovirus, minute virus of mice, on cultured mouse cells. J. Virol. 1977, 24:211-221.
40. Linser P., Bruning H., Armentrout R.W. Uptake of minute virus of mice into cultured rodent cells. J. Virol. 1979, 31:537-545.
41. Mattei L.M., Cotmore S.F., Tattersall P., Iwasaki A. Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts. Virology 2013, 442:20-27.
42. Miranda F.A., Hassumi M.K., Guimaraes M.C., Simoes R.T., Silva T.G., Lira R.C., Rocha A.M., Mendes C.T., Donadi E.A., Soares C.P., Soares E.G. Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis. J. Histochem. Cytochem. 2009, 57:665-673.
43. Mourad-Zeidan A.A., Melnikova V.O., Wang H., Raz A., Bar-Eli M. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am. J. Pathol. 2008, 173:1839-1852.
44. Mousset S., Cornelis J., Spruyt N., Rommelaere J. Transformation of established murine fibroblasts with an activated cellular Harvey-ras oncogene or the polyoma virus middle T gene increases cell permissiveness to parvovirus minute-virus-of-mice. Biochimie 1986, 68:951-955.
45. Nam H.J., Gurda-Whitaker B., Gan W.Y., Ilaria S., McKenna R., Mehta P., Alvarez R.A., Agbandje-McKenna M. Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J. Biol. Chem. 2006, 281:25670-25677.
46. Nonnenmacher M., Weber T. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 2011, 10:563-576.
47. Nuesch J.P., Lachmann S., Corbau R., Rommelaere J. Regulation of minute virus of mice NS1 replicative functions by atypical PKClambda in vivo. J. Virol. 2003, 77:433-442.
48. Nuesch J.P., Lacroix J., Marchini A., Rommelaere J. Molecular pathways: rodent parvoviruses-mechanisms of oncolysis and prospects for clinical cancer treatment. Clin. Cancer Res. 2012, 18:3516-3523.
49. Pacis R.A., Pilat M.J., Pienta K.J., Wojno K., Raz A., Hogan V., Cooper C.R. Decreased galectin-3 expression in prostate cancer. Prostate 2000, 44:118-123.
50. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., Dennis J.W. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306:120-124.
51. Riolobos L., Valle N., Hernando E., Maroto B., Kann M., Almendral J.M. Viral oncolysis that targets Raf-1 signaling control of nuclear transport. J. Virol. 2010, 84:2090-2099.
52. Rommelaere J., Geletneky K., Angelova A.L., Daeffler L., Dinsart C., Kiprianova I., Schlehofer J.R., Raykov Z. Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev. 2010, 21:185-195.
53. Sathisha U.V., Jayaram S., Harish Nayaka M.A., Dharmesh S.M. Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources. Glycoconj. J. 2007, 24:497-507.
54. Shankar J., Wiseman S.M., Meng F., Kasaian K., Strugnell S., Mofid A., Gown A., Jones S.J., Nabi I.R. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer. J. Pathol. 2012, 228:56-66.
55. St-Pierre C., Ouellet M., Giguere D., Ohtake R., Roy R., Sato S., Tremblay M.J. Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Antimicrob. Agents Chemother. 2012, 56:154-162.
56. Takenaka Y., Fukumori T., Raz A. Galectin-3 and metastasis. Glycoconj. J. 2004, 19:543-549.
57. Tattersall P., Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 1983, 46:944-955.
58. Tattersall P., Cawte P.J., Shatkin A.J., Ward D.C. Three structural polypeptides coded for by minite virus of mice, a parvovirus. J. Virol. 1976, 20:273-289.
59. Tattersall P., Shatkin A.J., Ward D.C. Sequence homology between the structural polypeptides of minute virus of mice. J. Mol. Biol. 1977, 111:375-394.
60. Vasta G.R. Galectins as pattern recognition receptors: structure, function, and evolution. Adv. Exp. Med. Biol. 2012, 946:21-36.
61. Vihinen-Ranta M., Parrish C.R. Cell infection processes of autonomous parvoviruses. Parvoviruses 2006, Hodder Arnold, London, UK. J.R. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
62. Wang Y., Balan V., Gao X., Reddy P.G., Kho D., Tait L., Raz A. The significance of galectin-3 as a new basal cell marker in prostate cancer. Cell Death Dis. 2013, 4:e753.
63. Wang Y., Nangia-Makker P., Tait L., Balan V., Hogan V., Pienta K.J., Raz A. Regulation of prostate cancer progression by galectin-3. Am. J. Pathol. 2009, 174:1515-1523.
64. Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003, 102:3927-3933.
65. Williams W.P., Tamburic L., Astell C.R. Increased levels of B1 and B2 SINE transcripts in mouse fibroblast cells due to minute virus of mice infection. Virology 2004, 327:233-241.
66. Wollmann G., Tattersall P., van den Pol A.N. Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J. Virol. 2005, 79:6005-6022.
67. Woodward A.M., Mauris J., Argueso P. Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. J. Virol. 2013, 87:5841-5847.
68. Yang M.L., Chen Y.H., Wang S.W., Huang Y.J., Leu C.H., Yeh N.C., Chu C.Y., Lin C.C., Shieh G.S., Chen Y.L., Wang J.R., Wang C.H., Wu C.L., Shiau A.L. Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J. Virol. 2011, 85:10010-10020.
69. Yeung D.E., Brown G.W., Tam P., Russnak R.H., Wilson G., Clark-Lewis I., Astell C.R. Monoclonal antibodies to the major nonstructural nuclear protein of minute virus of mice. Virology 1991, 181:35-45.
70. Zeicher M., Spegelaere P., Horth M., Gancberg D., Karim A., Dupont F. Oncoselective parvoviral vector-mediated gene therapy of cancer. Oncol. Res. 2003, 13:437-444.